RobertoPecoits-Filho Ann ArborUnited States

Dr. Pecoits-Filho is a Distinguished Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Adjunct Professor of Medicine at the University of Michigan. He is the current Chair of the International Society of Nephrology iNET-CKD. Dr. Pecoits-Filho is the Scientific Director of the DOPPS Program, a multinational study on practice patterns and outcomes in chronic kidney disease, hemodialysis and peritoneal dialysis and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).

Wcn26 Post edited Speaker Card

https://storage.unitedwebnetwork.com/files/486/776936-35623-Roberto Pecoits Filho_356585.png

29 March 2026

Time	Session

9:25 a.m. 10:55 a.m.	HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials AdeeraLevin Chair alevin@providencehealth.bc.caCanada Andrea Viecelli Chair andrea.k.viecelli@gmail.comSwitzerland RobertoPecoits-Filho Chair roberto.pecoits@arborresearch.orgUnited States ASPIRE (Aspirin in Dialysis PTS/ China): Large Pragmatic Trial XueqingYu Speaker yuxueqing@gdph.org.cnChina RESOLVE (NA CONCENTRTION IN DIALYSIS POPULATIONS: GLOBAL): CLUSTER RANDOMIZED TRIAL MegJardine Speaker meg.jardine@sydney.edu.auAustralia VOICE ShuchiAnand Speaker sanand2@stanford.eduUnited States TEST PD JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia Renal Life Cycle HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far Selvin Sundar RajMani Speaker selvinsr@gmail.comIndia Q&A Main Hall

Time

Session

9:25 a.m.

10:55 a.m.

HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials

AdeeraLevin Chair alevin@providencehealth.bc.caCanada

Andrea Viecelli Chair andrea.k.viecelli@gmail.comSwitzerland

RobertoPecoits-Filho Chair roberto.pecoits@arborresearch.orgUnited States

ASPIRE (Aspirin in Dialysis PTS/ China): Large Pragmatic Trial

XueqingYu Speaker yuxueqing@gdph.org.cnChina
RESOLVE (NA CONCENTRTION IN DIALYSIS POPULATIONS: GLOBAL): CLUSTER RANDOMIZED TRIAL

MegJardine Speaker meg.jardine@sydney.edu.auAustralia
VOICE

ShuchiAnand Speaker sanand2@stanford.eduUnited States
TEST PD

JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia
Renal Life Cycle

HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far

Selvin Sundar RajMani Speaker selvinsr@gmail.comIndia
Q&A

Main Hall

30 March 2026

Time	Session

9:25 a.m. 10:55 a.m.	Integrating Care for Cardiovascular-Kidney-Metabolic Health Across the Lifespan IK Is Kidney Dysfunction in Heart Failure More Than Just Low Cardiac Output? BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia Is Metabolic Dysfunction in Cardiovascular-Kidney-Metabolic Syndrome More Than Just Hyperglycemia and Obesity? HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Kidney at the Center of Conservative Kidney Management Syndrome MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan What’s Next in Cardiovascular-Kidney-Metabolic Therapy? RobertoPecoits-Filho Speaker roberto.pecoits@arborresearch.orgUnited States Q&A 501 - 502
12:50 p.m. 1:50 p.m.	Industry Symposium 45 MasaomiNangaku Chair mnangaku@m.u-tokyo.ac.jpJapan Welcome & Introductions MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan UACR: Hidden Marker of Heart and Kidney Risk PamKushner Speaker pamkushner@hotmail.comUnited States RobertoPecoits-Filho Speaker roberto.pecoits@arborresearch.orgUnited States The Impact of RAAS Dysregulation in Cardiorenal Disease Sydney Tang Speaker scwtang@hku.hkHong Kong, China 304